
Adapthealth Corp
NASDAQ:AHCO

Intrinsic Value
The intrinsic value of one
AHCO
stock under the Base Case scenario is
27.9
USD.
Compared to the current market price of 8.98 USD,
Adapthealth Corp
is
Undervalued by 68%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Adapthealth Corp
Fundamental Analysis


Revenue & Expenses Breakdown
Adapthealth Corp
Balance Sheet Decomposition
Adapthealth Corp
Current Assets | 755.8m |
Cash & Short-Term Investments | 109.7m |
Receivables | 408m |
Other Current Assets | 238m |
Non-Current Assets | 3.7B |
PP&E | 618.4m |
Intangibles | 2.8B |
Other Non-Current Assets | 332.1m |
Free Cash Flow Analysis
Adapthealth Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Adapthealth Corp
Revenue
|
4B
USD
|
Cost of Revenue
|
-3.1B
USD
|
Gross Profit
|
893.6m
USD
|
Operating Expenses
|
-562.1m
USD
|
Operating Income
|
331.5m
USD
|
Other Expenses
|
-254.8m
USD
|
Net Income
|
76.7m
USD
|
AHCO Profitability Score
Profitability Due Diligence
Adapthealth Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Score
Adapthealth Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
AHCO Solvency Score
Solvency Due Diligence
Adapthealth Corp's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Score
Adapthealth Corp's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AHCO Price Targets Summary
Adapthealth Corp
According to Wall Street analysts, the average 1-year price target for
AHCO
is 13.26 USD
with a low forecast of 9.6 USD and a high forecast of 16.8 USD.
Dividends
Current shareholder yield for AHCO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AHCO
stock under the Base Case scenario is
27.9
USD.
Compared to the current market price of 8.98 USD,
Adapthealth Corp
is
Undervalued by 68%.